Tolfenamic Acid Derivatives: A New Class of Transcriptional Modulators with Potential Therapeutic Applications for Alzheimer’s Disease and Related Disorders

The field of Alzheimer’s disease (AD) has witnessed recent breakthroughs in the development of disease-modifying biologics and diagnostic markers. While immunotherapeutic interventions have provided much-awaited solutions, nucleic acid-based tools represent other avenues of intervention; however, th...

Descripción completa

Detalles Bibliográficos
Autores principales: Hill, Jaunetta, Shalaby, Karim E., Bihaqi, Syed W., Alansi, Bothaina H., Barlock, Benjamin, Parang, Keykavous, Thompson, Richard, Ouararhni, Khalid, Zawia, Nasser H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10607430/
https://www.ncbi.nlm.nih.gov/pubmed/37894896
http://dx.doi.org/10.3390/ijms242015216

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10607430/
https://www.ncbi.nlm.nih.gov/pubmed/37894896
http://dx.doi.org/10.3390/ijms242015216

Ejemplares similares